PEDRO NAM: Open Payments
NPI 1679673743 · LOXAHARCHEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 75 payments from 15 companies in 2025. Trend: 2023 $957 · 2024 $1,399 · 2025 $1,559
Food & beverage: $1,474Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $371 |
| ABBVIE INC. | 15 | $212 |
| PFIZER INC. | 10 | $206 |
| Astellas Pharma US Inc | 5 | $190 |
| Amgen Inc. | 10 | $138 |
| Exact Sciences Corporation | 3 | $98 |
| Novo Nordisk Inc | 4 | $77 |
| Lilly USA, LLC | 4 | $65 |
| Abbott Laboratories | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: AIRSUPRA, NURTEC ODT, Veozah, ELIQUIS, Ozempic, FARXIGA, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
